<i id='72961BB9F1'><strike id='72961BB9F1'><tt id='72961BB9F1'><pre id='72961BB9F1'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
The cancer drug shortage isn’t new — and neither are the solutions 
Kenai launches with $82 million for Parkinson’s stem cell therapy
The cancer drug shortage isn’t new — and neither are the solutions 
Kale crackers and hibiscus tea: My five days on a 'fasting diet' 
Duchenne breakthrough therapy leaves behind pioneering families 
Titanic submersible victims' family mourns: 'Enormous tragedy and devastation' 
Guidelines to prevent youth baseball injuries need more muscle 
House looks to weaken Medicare negotiation 
Drug repurposing or repositioning? The language matters 
Clinical trials giant ICON acquires HumanFirst 
DIEP, the 'gold standard' of breast reconstruction, is under threat 
Scientists unlock the key to scar 
Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies 
AstraZeneca loses challenge to Medicare drug price negotiation 
After affirmative action ruling, medical educators look to 'holistic review' 
